Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma-Reference-Cited by-同舟云学术

Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinoma

Published:2004 Issue:9 Volume:100 Page:1814-1822
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Pusztai Lajos,Gregory Betsy W.,Baggerly Keith A.,Peng Bo,Koomen John,Kuerer Henry M.,Esteva Francisco J.,Symmans W. Fraser,Wagner Peter,Hortobagyi Gabriel N.,Laronga Christine,Semmes O. John,Wright George L.,Drake Richard R.,Vlahou Antonia

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference17 articles.

1. Use of proteomic patterns in serum to identify ovarian cancer

2. A Novel Approach Toward Development of a Rapid Blood Test for Breast Cancer

3. Diagnosis of Ovarian Cancer Using Decision Tree Classification of Mass Spectral Data

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncoproteomics by 3D MALDI with MRI-PET Imaging in Cancer;Pharmacoproteomics;2024

2. Systemic Inflammatory Response as a Prognostic Factor in Breast Cancer. Part I. Tumor-Promoting Inflammation. Serum Inflammatory Markers;Annals of the Russian academy of medical sciences;2022-12-28

3. Breast Cancer Biomarkers in Circulation;Cancer Biomarkers in Body Fluids;2016-11-26

4. Clinical proteomics and breast cancer;The Surgeon;2015-10

5. Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery;International Journal of Cancer;2015-06-04